Informações:
Falhas:
ID
22306
Descrição
The High-Dose Aldesleukin (IL-2) "Select" Trial for Patients With Metastatic Renal Cell Carcinoma; ODM derived from: https://clinicaltrials.gov/show/NCT00554515
Link
https://clinicaltrials.gov/show/NCT00554515
Palavras-chave
Versões (1)
- 29/05/2017 29/05/2017 -
Transferido a
29 de maio de 2017
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility Metastatic Renal Cell Carcinoma NCT00554515
Eligibility Metastatic Renal Cell Carcinoma NCT00554515
- StudyEvent: Eligibility
Similar models
Eligibility Metastatic Renal Cell Carcinoma NCT00554515
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
histologically confirmed renal cell carcinoma, metastatic or unresectable
Item
patients must have histologically confirmed renal cell carcinoma that is metastatic or unresectable.
boolean
C0007134 (UMLS CUI [1,1])
C0679557 (UMLS CUI [1,2])
C2939420 (UMLS CUI [1,3])
C1336869 (UMLS CUI [1,4])
C0679557 (UMLS CUI [1,2])
C2939420 (UMLS CUI [1,3])
C1336869 (UMLS CUI [1,4])
measurable disease, solitary mass, cytology/histology
Item
if patients have measurable disease restricted to a solitary lesion, its neoplastic nature should be confirmed by cytology/histology.
boolean
C1513041 (UMLS CUI [1,1])
C1265601 (UMLS CUI [1,2])
C0019638 (UMLS CUI [1,3])
C0010819 (UMLS CUI [1,4])
C1265601 (UMLS CUI [1,2])
C0019638 (UMLS CUI [1,3])
C0010819 (UMLS CUI [1,4])
tissue block
Item
patients must provide access to tissue blocks containing adequate tumor for interpretation and analysis.
boolean
C2316369 (UMLS CUI [1,1])
C2317347 (UMLS CUI [1,2])
C2317347 (UMLS CUI [1,2])
measurable disease
Item
patients must have measurable disease.
boolean
C1513041 (UMLS CUI [1])
ecog, karnofsky
Item
patients must have good performance status (ecog 0 or 1; karnofsky ps 100-80%).
boolean
C1520224 (UMLS CUI [1])
C0206065 (UMLS CUI [2])
C0206065 (UMLS CUI [2])
organ function
Item
patients must have adequate organ function.
boolean
C0678852 (UMLS CUI [1])
contraindication vasopressor agents
Item
patients must have no contraindication of vasopressor agents.
boolean
C1301624 (UMLS CUI [1,1])
C0042397 (UMLS CUI [1,2])
C0042397 (UMLS CUI [1,2])
age
Item
patients must be ≥ 18 years of age.
boolean
C0001779 (UMLS CUI [1])
prior chemotherapy
Item
patients who have received systemic therapy for metastatic disease.
boolean
C1514457 (UMLS CUI [1])
organ allografts
Item
patients with organ allografts.
boolean
C1515895 (UMLS CUI [1,1])
C0524930 (UMLS CUI [1,2])
C0524930 (UMLS CUI [1,2])
systemic corticosteroid therapy
Item
patients who require or are likely to require systemic corticosteroid therapy for intercurrent illness.
boolean
C4053960 (UMLS CUI [1])
comorbidity, risk, immunotherapy
Item
patients with any significant medical disease other than the malignancy (e.g. copd, patients with ascites or pleural effusions), which in the opinion of the investigator would significantly increase the risk of immunotherapy.
boolean
C0009488 (UMLS CUI [1,1])
C0035647 (UMLS CUI [1,2])
C0021083 (UMLS CUI [1,3])
C0035647 (UMLS CUI [1,2])
C0021083 (UMLS CUI [1,3])
history of malignant disease other than surgically cured non-melanoma skin cancer, carcinoma-in-situ or stage i carcinoma of the cervix
Item
patients with a history of another malignancy within the past 5 years other than surgically cured non-melanoma skin cancer, carcinoma-in-situ or stage i carcinoma of the cervix.
boolean
C0455471 (UMLS CUI [1])
C0007114 (UMLS CUI [2,1])
C0332644 (UMLS CUI [2,2])
C0851140 (UMLS CUI [3])
C0278575 (UMLS CUI [4])
C0007114 (UMLS CUI [2,1])
C0332644 (UMLS CUI [2,2])
C0851140 (UMLS CUI [3])
C0278575 (UMLS CUI [4])